Episode 30. Controversies in Prostate Cancer with Dr Dennis King
Prostate cancer is the second most commonly diagnosed cancer among men and the second most common cause of death from cancer in men, yet many prostate cancers are not fatal and some autopsy series have demonstrated up to 50% or more silent prostate cancers in men over the age of 70 years.
Prostate cancer is the second most commonly diagnosed cancer among men and the second most common cause of death from cancer in men, yet many prostate cancers are not fatal and some autopsy series have demonstrated up to 50% or more silent prostate cancers in men over the age of 70 years. At 50 years of age some studies suggest a 40% chance of harbouring a latent cancer, 16% chance of developing an apparent and invasive cancer and 2.9% risk of death from prostate cancer. These facts raise several controversies regarding management and the approach to surgical treatment is also subject to debate.
To discuss this subject in more detail we are joined by expert urological surgeon Dr Dennis King who covers:
· Approaches to diagnosis of prostate cancer
· Separating indolent disease from lethal and aggressive disease
· Surgical approaches including robotic surgery
I enjoyed this conversation with Dennis immensely and am very pleased to invite you to the episode.
Useful references include:
- urologyassociates.com.au
- ghr.nlm.nih.gov
To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au
Dr Luke Crantock MBBS, FRACP, is a gastroenterologist in practice for over 25 years. He is the founder of The Centre for GI Health, based in Melbourne Australia and is passionate about educating General Practitioners and patients on disease prevention and how to manage and improve their digestive health.
Episode 22. Stroke with Dr Doug Crompton
It is estimated that more than 56,000 strokes will be experienced by Australians this year (new and recurrent) and that half of Australians are living with the effects of a stroke which remains the third leading cause of death in Australia and kills more women than breast cancer and more men than prostate cancer. As more than 80% of strokes may be prevented and four in 10 stroke survivors have a recurrent stroke within a decade it is very important we understand the aetiology of strokes and how we may intervene effectively to reduce incidence and morbidity.
It is estimated that more than 56,000 strokes will be experienced by Australians this year (new and recurrent) and that half of Australians are living with the effects of a stroke which remains the third leading cause of death in Australia and kills more women than breast cancer and more men than prostate cancer. As more than 80% of strokes may be prevented and four in 10 stroke survivors have a recurrent stroke within a decade it is very important we understand the aetiology of strokes and how we may intervene effectively to reduce incidence and morbidity.
In this episode we have a conversation with Dr Doug Crompton head of neurology at Northern Hospital who discusses:
· Aetiology of CVA
· Diagnosis
· Importance of thrombolytic therapy
· Place for clot retrieval
· Primary and secondary prevention
This was a very interesting conversation with Doug, covering this fascinating topic and I am certain you will find the conversation extremely valuable.
Useful references include:
- strokefoundation.org.au
- pubmed.ncbi.nlm.nih.gov/Epidemiology: Advancing our understanding of disease
- pubmed.nbo.Ovbiagele.et.al.2011
To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au
Dr Luke Crantock MBBS, FRACP, is a gastroenterologist in practice for over 25 years. He is the founder of The Centre for GI Health, based in Melbourne Australia and is passionate about educating General Practitioners and patients on disease prevention and how to manage and improve their digestive health.